XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
  UK
  USA
  World
  India
  South Africa
  New Zealand
  Australia
  Canada Healthcare
  China Healthcare
  Africa
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Nov 17th, 2006 - 22:35:04

Healthcare Channel
subscribe to Healthcare newsletter

Medical News : Healthcare

   DISCUSS   |   EMAIL   |   PRINT
Cost-effectiveness of drugs may vary across borders
Apr 18, 2005, 21:07, Reviewed by: Dr.

�Because the healthcare systems in different countries vary considerably, we shouldn�t automatically assume that a new drug that gives good value for money in one country will do so an another�

 
A study published in the journal Value in Health reviews variations in estimates of cost-effectiveness of pharmaceuticals from country to country. Data showed that the results seen in one country are not necessarily applicable in another and that decision makers need to interpret data from other countries very carefully.

This research was conducted within and across multiple countries in Western Europe to assess the generalizability of the cost-effectiveness of new pharmaceuticals. While health results of clinical studies of drugs tend to be transferable from one area to the next, the cost-effectiveness of drugs is dependent on location. This information is becoming increasingly important to healthcare policy makers.

�Because the healthcare systems in different countries vary considerably, we shouldn�t automatically assume that a new drug that gives good value for money in one country will do so an another,� states Professor Michael Drummond, co-author of the study. Study results emphasized the fact that economic evaluations in one country give little basis on which to predict cost-effectiveness across borders.

Factors affecting the variations include demography and epidemiology of disease, difference in clinical practice patterns, and differences in relative prices cross-country. This variability is a particular concern for decision makers, those conducting economic studies and particularly pharmaceutical manufacturers, who may have to consider repeating studies in every possible setting.
 

- This study is published in Value in Health
 

http://www.blackwellpublishing.com/journal.asp?ref=1098-3015

 
Subscribe to Healthcare Newsletter
E-mail Address:

 

Michael Drummond, BSc, MCom, DPhil, is Professor of Health and Economics and Director of the Centre for Health Economics at theUniversity of York.

Corresponding author Jeremy Chancellor, MSc of Innovus Research (UK) Ltd. can be reached for questions at [email protected].

About Value in Health

Value in Health is a multidisciplinary peer-reviewed journal reporting on evaluations of medical technologies including pharmaceuticals, biologics, devices, procedures, and other health care interventions. As the official journal of the International Society for Pharmacoeconomics and Outcomes Research, the Journal provides a scientific forum for communicating health economics and outcomes research methods and findings.


Related Healthcare News

Indians among worst affected by TB in Britain
Future of sexual and reproductive health at tipping point according to global study
Profiles of serial killers have limitations
Concerns over abortion law in the US state of South Dakota
European Alcohol Strategy Threatened by Industry Tactics
Lawrence Berkeley National Laboratory Opens the National Center for X-ray Tomography (NCXT)
States That Easily Grant Immunization Exemptions Have Higher Incidence Of Whooping Cough
Study calls for 39 percent more family physicians in USA
Mental health units should not be exempt from smoking ban
Community model effective in allotting anti-AIDS medication


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us